1. Jazz Pharmaceuticals to acquire GW Pharmaceuticals PLC, creating an innovative, high-growth, global biopharma leader. https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-acquire-gw-pharmaceuticals-plc-creating
2. GW Pharmaceuticals. Development pipeline. www.gwpharm.co.uk/hcp/development-pipeline
3. Imcyse enters into research collaboration and license agreement for its Imotope™ Technology with Pfizer in rheumatoid arthritis. www.imcyse.com/en/news/view/18/Imcyse+Enters+into+Research+Collaboration+and+License+Agreement+for+its+ImotopeTM+Technology+with+Pfizer+in+Rheumatoid+Arthritis
4. Imcyse. Technology platform. www.imcyse.com/en/technology-platform
5. Horizon Therapeutics PLC to acquire Viela Bio, Inc. to significantly expand development pipeline and grow rare disease medicine portfolio. www.businesswire.com/news/home/20210201005296/en/Horizon-Therapeutics-plc-to-Acquire-Viela-Bio-Inc.to-Significantly-Expand-Development-Pipeline-and-Grow-Rare-Disease-Medicine-Portfolio